Dr. Igor Atabekov (Oncologist) Fenbendazole, Mebendazole, Ivermectin against cancer.
i know it works 😮. i actually cured my wife’s multiple myeloma blood cancer w/ raw bitter apricot seed pits that’s after it came back. she had 9 months of chemotherapy they to treatments of the most toxic chemo known to man to man that almost killed her twice 😢she had 2 stem cell transplants all failed 14 months of remission then it came back it only took $5 worth of apricot seed pits & 10 weeks she was cancer free w/ no side effects. hallelujah Jesus it was He i prayed to . then the seeds were literally brought to my front door via my mother in law God bless her please pray for her she struggles with spinal stenosis & her mind is fading.
I have a relative who is a top class vet and so is her husband. They have told me that many vets find that ivermectin can work very well in cancer in many animals, especially in dogs. However we all know that finding a cure for cancer, especially one for $20, is not in the interest of the drug companies who would rather treat you at a huge cost for many years.
My husband did the fenbedazole protocol at the same time as radiation for stage 4 prostate cancer that was visibly in lymphatic system outside of prostate. With success…cancer is gone! 😊
I am a nurse & a father. I was diagnosed with cancer (colorectal) in 2020. I can say that these drugs DO work as evidenced by my scan that showed a decrease in tumor size. 1.9cm down to 1.4cm in one month.
I take both Fenbendazole and artemisinin after being treated with low-dose chemo for breast cancer. Still cancer free after 5 years.
Ivermectin is a part of a clinical trial on humans at city of Hope in America. So far it is working with a combination drug . It is also working on me , Stage four for three years now. Just wish I had started it sooner.
⭐⭐⭐⭐⭐ Thank the stars above for Glasgow University's and City of Hope's recent proof of efficacy for fenbendazole, ivermectin, mebendazole.
Dr Helen Rippon, Chief Executive of Worldwide Cancer Research:
"This research could be a real game-changer for prostate cancer patients. Docetaxel is the main chemotherapy used to treat prostate cancer, but many patients end up developing resistance to the drug and their cancer comes back.
This bold new idea shows how we can use already existing medicines to bolster the effects of chemotherapy and hopefully improve outcomes for people with prostate cancer. We are excited to follow the progress of the research team as they take their work forward into clinical trials."
Dr Samuel Godfrey, Senior Research Information Manager at Cancer Research UK:
"Combining existing medicines with different cancer drugs is an exciting area of research, and this study shows some promising results which could lead to improved treatments for prostate cancer.
Out of the hundreds of medicines investigated, few would have suspected that an inexpensive worming treatment could so drastically increase cancer cell death in the lab. The next step will be to test this new drug combination in people with prostate cancer to see if it's safe and performs better than current treatments"
Novel drug combo shows promise against triple-negative breast cancer
By Letisia Marquez Mar. 02, 2021
Research
City of Hope scientists have combined a checkpoint inhibitor with an anti-parasitic drug, ivermectin, to successfully treat triple-negative breast cancer in preclinical research, according to a study published March 2 in npj Breast Cancer journal. (Ivermectin is also currently being used in clinical trials to treat and prevent COVID-19.)
Triple-negative breast cancer is a difficult type of cancer to treat because the tumor cells lack three key proteins — receptors for the hormones estrogen and progesterone and the protein HER2. Doctors now treat breast cancer based on targeting these three key proteins, but without them, triple-negative breast cancer has limited treatment options.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9437363/
Korean J Physiol Pharmacol. 2022 Sep 1; 26(5): 377–387.
Published online 2022 Sep 1. doi: 10.4196/kjpp.2022.26.5.377
PMCID: PMC9437363
PMID: 36039738
Anti-cancer effects of fenbendazole on 5-fluorouracil-resistant colorectal cancer cells
Deokbae Park,#1,# Jung-Hee Lee,#2,# and Sang-Pil Yooncorresponding author3,*
Author information Article notes Copyright and License information PMC Disclaimer
Go to:
Abstract
Benzimidazole anthelmintic agents have been recently repurposed to overcome cancers resistant to conventional therapies. To evaluate the anti-cancer effects of benzimidazole on resistant cells, various cell death pathways were investigated in 5-fluorouracil-resistant colorectal cancer cells. The viability of wild-type and 5-fluorouracil-resistant SNU-C5 colorectal cancer cells was assayed, followed by Western blotting.
Flow cytometry assays for cell death and cell cycle was also performed to analyze the anti-cancer effects of benzimidazole. When compared with albendazole, fenbendazole showed higher susceptibility to 5-fluorouracil-resistant SNU-C5 cells and was used in subsequent experiments.
Flow cytometry revealed that fenbendazole significantly induces apoptosis as well as cell cycle arrest at G2/M phase on both cells. When compared with wild-type SNU-C5 cells, 5-fluorouracil-resistant SNU-C5 cells showed reduced autophagy, increased ferroptosis and ferroptosis-augmented apoptosis, and less activation of caspase-8 and p53.
These results suggest that fenbendazole may be a potential alternative treatment in 5-fluorouracil-resistant cancer cells, and the anticancer activity of fenbendazole does not require p53 in 5-fluorouracil-resistant SNU-C5 cells.
Keywords: Apoptosis, Colorectal cancer, Drug resistance, Fenbendazole, p53
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9437363/
Korean J Physiol Pharmacol. 2022 Sep 1; 26(5): 377–387.
Published online 2022 Sep 1. doi: 10.4196/kjpp.2022.26.5.377
PMCID: PMC9437363
PMID: 36039738
Anti-cancer effects of fenbendazole on 5-fluorouracil-resistant colorectal cancer cells
Deokbae Park,#1,# Jung-Hee Lee,#2,# and Sang-Pil Yooncorresponding author3,*
Author information Article notes Copyright and License information PMC Disclaimer
Go to:
Abstract
Benzimidazole anthelmintic agents have been recently repurposed to overcome cancers resistant to conventional therapies. To evaluate the anti-cancer effects of benzimidazole on resistant cells, various cell death pathways were investigated in 5-fluorouracil-resistant colorectal cancer cells. The viability of wild-type and 5-fluorouracil-resistant SNU-C5 colorectal cancer cells was assayed, followed by Western blotting.
Flow cytometry assays for cell death and cell cycle was also performed to analyze the anti-cancer effects of benzimidazole. When compared with albendazole, fenbendazole showed higher susceptibility to 5-fluorouracil-resistant SNU-C5 cells and was used in subsequent experiments.
Flow cytometry revealed that fenbendazole significantly induces apoptosis as well as cell cycle arrest at G2/M phase on both cells. When compared with wild-type SNU-C5 cells, 5-fluorouracil-resistant SNU-C5 cells showed reduced autophagy, increased ferroptosis and ferroptosis-augmented apoptosis, and less activation of caspase-8 and p53.
These results suggest that fenbendazole may be a potential alternative treatment in 5-fluorouracil-resistant cancer cells, and the anticancer activity of fenbendazole does not require p53 in 5-fluorouracil-resistant SNU-C5 cells.
Keywords: Apoptosis, Colorectal cancer, Drug resistance, Fenbendazole, p53
MM&cyanides: How did you make the seeds to be a round thing?
Have a friend in late stage MM, and she totally avoidds all anti-oxidants.
Her instinct and what she read is all justified.
I think sometimes we need some antioxidants, and we shoud use other stuff meanwhile ramped up to prevent the cancer from hopping.
Did you do any other interventions?
But how did you time that?
Did you have something like 5 days on and 2 off and in the 2 take ivermectin fenben Vit C high dose (so oxidative, what dose would that be, and to which cells?) MB NAC or liposomal Gluthation?
Did you do a in-vitro assession which antiparasitic works best for the MM?
Found only that comparing effect in vitro of nodocazole ivm fenben etc:
Targeting the Microtubular Network as a New Antimyeloma Strategy
Rentian Feng et al
https://aacrjournals.org/mct/article/10/10/1886/91048/Targeting-the-Microtubular-Network-as-a-New
Have you heard of curcumine as a good intervention for MM?
Thanks!
Andi